Cargando…

Combined Inactivation of MYC and K-Ras Oncogenes Reverses Tumorigenesis in Lung Adenocarcinomas and Lymphomas

BACKGROUND: Conditional transgenic models have established that tumors require sustained oncogene activation for tumor maintenance, exhibiting the phenomenon known as “oncogene-addiction.” However, most cancers are caused by multiple genetic events making it difficult to determine which oncogenes or...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tran, Phuoc T., Fan, Alice C., Bendapudi, Pavan K., Koh, Shan, Komatsubara, Kim, Chen, Joy, Horng, George, Bellovin, David I., Giuriato, Sylvie, Wang, Craig S., Whitsett, Jeffrey A., Felsher, Dean W.
Formato:	Texto
Lenguaje:	English
Publicado:	Public Library of Science 2008
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2365560/ https://www.ncbi.nlm.nih.gov/pubmed/18461184 http://dx.doi.org/10.1371/journal.pone.0002125

Ejemplares similares

Hepatotoxin-Induced Changes in the Adult Murine Liver Promote MYC-Induced Tumorigenesis
por: Beer, Shelly, et al.
Publicado: (2008)

MYC ASO Impedes Tumorigenesis and Elicits Oncogene Addiction in Autochthonous Transgenic Mouse Models of HCC and RCC
por: Dhanasekaran, Renumathy, et al.
Publicado: (2020)

Lipid nanoparticles that deliver IL-12 messenger RNA suppress tumorigenesis in MYC oncogene-driven hepatocellular carcinoma
por: Lai, Ian, et al.
Publicado: (2018)

Molecular Analysis of Oncogenes, ras Family Genes (N‐ras, K‐ras, H‐ras), myc Family Genes (c‐myc, N‐myc) and mdm2 in Natural Killer Cell Neoplasms
por: Sugimoto, Kei‐ji, et al.
Publicado: (2002)

Developmental Context Determines Latency of MYC-Induced Tumorigenesis
por: Beer, Shelly, et al.
Publicado: (2004)

Sos-mediated cross activation of wild-type Ras by oncogenic Ras is essential for tumorigenesis
por: Jeng, Hao-Hsuan, et al.
Publicado: (2012)

MYC and Twist1 cooperate to drive metastasis by eliciting crosstalk between cancer and innate immunity
por: Dhanasekaran, Renumathy, et al.
Publicado: (2020)

Ras Oncogene-Mediated Progressive Silencing of Extracellular Superoxide Dismutase in Tumorigenesis
por: Cammarota, Francesca, et al.
Publicado: (2015)

A mathematical model of tumor regression and recurrence after therapeutic oncogene inactivation
por: Hori, Sharon S., et al.
Publicado: (2021)

Combined Analysis of Murine and Human Microarrays and ChIP Analysis Reveals Genes Associated with the Ability of MYC To Maintain Tumorigenesis
por: Wu, Chi-Hwa, et al.
Publicado: (2008)

BIM mediates oncogene inactivation-induced apoptosis in multiple transgenic mouse models of acute lymphoblastic leukemia
por: Li, Yulin, et al.
Publicado: (2016)

BTB-Zinc Finger Oncogenes Are Required for Ras and Notch-Driven Tumorigenesis in Drosophila
por: Doggett, Karen, et al.
Publicado: (2015)

Anti-miR-17 therapy delays tumorigenesis in MYC-driven hepatocellular carcinoma (HCC)
por: Dhanasekaran, Renumathy, et al.
Publicado: (2017)

Correction: Combined Analysis of Murine and Human Microarrays and ChIP Analysis Reveals Genes Associated with the Ability of MYC To Maintain Tumorigenesis
por: Wu, Chi-Hwa, et al.
Publicado: (2013)

Inactivation of RASA1 promotes melanoma tumorigenesis via R-Ras activation
por: Sung, Hyeran, et al.
Publicado: (2016)

SIRT1 and c-Myc Promote Liver Tumor Cell Survival and Predict Poor Survival of Human Hepatocellular Carcinomas
por: Jang, Kyu Yun, et al.
Publicado: (2012)

Metabolic vulnerabilities of MYC-induced cancer
por: Gouw, Arvin M., et al.
Publicado: (2016)

Oncogene addiction: resetting the safety switch?
por: Li, Yulin, et al.
Publicado: (2014)

BIM-mediated apoptosis and oncogene addiction
por: Li, Yulin, et al.
Publicado: (2016)

Rodent fibroblast tumours expressing human myc and ras genes: growth, metastasis and endogenous oncogene expression.
por: Wyllie, A. H., et al.
Publicado: (1987)

Susceptibility to apoptosis is differentially regulated by c-myc and mutated Ha-ras oncogenes and is associated with endonuclease availability.
por: Arends, M. J., et al.
Publicado: (1993)

Oncogenic K-ras confers SAHA resistance by up-regulating HDAC6 and c-myc expression
por: Wang, Qun, et al.
Publicado: (2016)

A quantitative PCR method to detect blood microRNAs associated with tumorigenesis in transgenic mice
por: Fan, Alice C, et al.
Publicado: (2008)

Cooperativity of Oncogenic K-Ras and Downregulated p16/INK4A in Human Pancreatic Tumorigenesis
por: Chang, Zhe, et al.
Publicado: (2014)

Ribozyme-mediated inactivation of mutant K-ras oncogene in a colon cancer cell line
por: Tokunaga, T, et al.
Publicado: (2000)

A new mutation-independent approach to cancer therapy: Inhibiting oncogenic RAS and MYC, by targeting mitochondrial biogenesis
por: Ozsvari, Bela, et al.
Publicado: (2017)

Oncogenic RAS promotes MYC protein stability by upregulating the expression of the inhibitor of apoptosis protein family member Survivin
por: Chang, Wen-Hsuan, et al.
Publicado: (2022)

The Role of Wild-Type RAS in Oncogenic RAS Transformation
por: Sheffels, Erin, et al.
Publicado: (2021)

Prolonged sulforaphane treatment does not enhance tumorigenesis in oncogenic K-ras and xenograft mouse models of lung cancer
por: Kombairaju, Ponvijay, et al.
Publicado: (2012)

K-Ras and B-Raf oncogenes inhibit colon epithelial polarity establishment through up-regulation of c-myc
por: Magudia, Kirti, et al.
Publicado: (2012)

Induction of non-apoptotic programmed cell death by oncogenic RAS in human epithelial cells and its suppression by MYC overexpression
por: Dendo, Kasumi, et al.
Publicado: (2018)

Myc and Ras oncogenes engage different energy metabolism programs and evoke distinct patterns of oxidative and DNA replication stress
por: Maya-Mendoza, Apolinar, et al.
Publicado: (2014)

The Molecular ‘Myc-anisms’ Behind Myc-Driven Tumorigenesis and the Relevant Myc-Directed Therapeutics
por: McAnulty, Jessica, et al.
Publicado: (2020)

RUNX3 inactivates oncogenic MYC through disruption of MYC/MAX complex and subsequent recruitment of GSK3β-FBXW7 cascade
por: Oei, Vincent, et al.
Publicado: (2023)

p19ARF is a critical mediator of both cellular senescence and an innate immune response associated with MYC inactivation in mouse model of acute leukemia
por: Yetil, Alper, et al.
Publicado: (2015)

AAV9-mediated telomerase activation does not accelerate tumorigenesis in the context of oncogenic K-Ras-induced lung cancer
por: Muñoz-Lorente, Miguel A., et al.
Publicado: (2018)

Expression of Concern: Cooperativity of Oncogenic K-Ras and Downregulated p16/INK4A in Human Pancreatic Tumorigenesis
Publicado: (2019)

Targeting c-MYC through Interference with NAMPT and SIRT1 and Their Association to Oncogenic Drivers in Murine Serrated Intestinal Tumorigenesis()
por: Brandl, Lydia, et al.
Publicado: (2019)

Downregulation of oncogenic RAS and c-Myc expression in MOLT-4 leukaemia cells by a salicylaldehyde semicarbazone copper(II) complex
por: Goh, Yan-Yih, et al.
Publicado: (2016)

Transforming ras oncogenes and multistage carcinogenesis.
por: Balmain, A.
Publicado: (1985)

Cannot write session to /tmp/vufind_sessions/sess_rjesvceicojjt98p6birmf6fs8